Benzisothiazoles and β-adrenoceptors: Synthesis and pharmacological investigation of novel propanolamine and oxypropanolamine derivatives in isolated rat tissues

Archives of Pharmacal Research

Volumn 28, Issue 12, 2005, Pages 1317-1323

  Morini, Giovanni ^a   Poli, Enzo ^a,b   Comini, Mara ^a   Menozzi, Alessandro ^b   Pozzoli, Cristina ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b Section of Pharmacology   (Italy)

Author keywords

1,2 Benzisothiazoles; Benzisothiazoloxypropanolamines; Benzisothiazolpropanolamines; Cardiac 1 adrenoceptors; Rat atria; Rat ileum

Indexed keywords

EID: 29944437307     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02977894     Document Type: Article

References (22)

1. Amoretti, L., Catellani, P. L., Impicciatore, M., and Cavaggioni, A., Biological properties of 1,2-benzisothiazole compounds. Local anaesthetic activity of amides and esters of 1,2-benzisothiazol-3-ylcarboxylic acid. II Farmaco, 27, 855-865, (1972).
2. 3-adrenergic agonists. Rev. Endocr. Metab. Dis., 2, 385-393 (2001).
3. Barocelli, E., Chiavarini, M., Ballabeni, V., Mingiardi, M. R., Morini, G., Ronchini, R., and Impicciatore, M., Pharmacological properties of new 1,2-benzisothiazolyl oxypropanolamines on cardiac and tracheal β-receptors. Boll. Soc. It. Biol. Sperim., 68, 445-451 (1992).
4. Benfield, P., Clissold, S. P., Brogden, R. N., Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders. Drugs, 31, 376-429 (1986).
5. 2 antagonist famotidine: in vitro studies. Agents Actions, 19, 180-187 (1986).
6. 3-adrenergic receptor. Mol. Pharmacol., 44, 1094-1104 (1993).
7. Candelore, M. R., Deng, L., Tota, L., Xiao-Ming, G., Amend, A., Liu, Y., Newbold, R., Cascieri, M. A., and Weber, A. E., Potent and selective human β-adrenergic receptor antagonists. J. Pharm. Exp. Ther., 290, 649-655 (1999).
8. Coruzzi, G. and Poli, E., Changes in duodenal contractility induced by "calcium antagonists" with different modes of action. Gen. Pharmacol., 18, 69-74 (1987).
9. Ishibashi, T., Ikeda, K., Ishida, K., Yasui, J., Tojima, R., Nakamura, M., and Ohno, Y., Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum. Eur. J. Pharmacol., 303, 247-251 (1996).
10. 3-adrenoceptor in the rat. Br. J. Pharmacol., 118, 2085-2098 (1996).
11. Kenakin, T. P., Drug antagonism, in Kenakin, T. P. (Ed.), Pharmacologic analysis of drug-receptor interaction. Raven Press, New York, pp. 205-225 (1987).
12. 2- adrenoceptors. Biol. Pharm. Bull., 17, 1023-1027 (1994).
13. Mingiardi, M. R., Maggiali, C. A., and Ronchini, F., 1,2-Benzisothiazole derivatives potentially active as β-blockers. Ateneo Parmense, Acta Nat., 19, 145-151 (1983).
14. Molina, E., Zappia, L., Amoretti, L., and Catellani, P. L., Biological properties of 1,2-benzisothiazole compounds. Spasmolytic activity of benzisothiazol-3-ylcarboxyamides. Ateneo Parmense, Acta Bio-Med., 45, 183-189 (1974).
15. Morini, G., Pozzoli, C., Adami, M., Poli, E., and Coruzzi, G., Synthesis of 1,2-benzisothiazole derivatives and investigation of their putative histaminergic activity. II Farmaco, 54, 740-746 (1999).
16. Morini, G., Pozzoli, C., Menozzi, A., Comini, M., and Poli, E., Synthesis of 1,2-benzisothiazolyloxypropanolamine derivatives and investigation of their activity at β-adrenoceptors. II Farmaco, 60, 810-817 (2005).
17. 1A receptor agonist flesinoxan in pigeons. Eur. J. Pharmacol., 325, 145-153 (1997).
18. 3-adrenoceptors in rat ileum. Br. J. Pharmacol., 127, 949-961 (1999).
19. 3-adrenergic receptor. Annu. Rev. Pharmacol. Toxicol., 37, 421-450 (1997).
20. 3 adrenergic receptor agonists. Bioorg. Med. Chem. Lett., 13, 2191-2194 (2003).
21. Von Franche, A., Frickel, F. F., Gries, J., Lehman, H. D., Lenke, D., and Ohnsorge, U., New β-sympatholytic agents: synthesis and pharmacological activity of isomeric benzothiazole and benzoxazole derivatives. Arzneim. Forsch. Drug Res., 30, 1831-1835 (1980).
22. Wadworth, A. N., Murdoch, D., and Brogden, R. N., Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs, 42, 468-510 (1991).